Rothschild Investment LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Rothschild Investment LLC’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35K	Sell	8 -1	-11%	-$284	﹤0.01%	2691
2026 Q1	$2.51K	Buy	9 +6	+200%	+$1.73K	﹤0.01%	2442
2025 Q4	$909	Buy	3 +1	+50%	+$312	﹤0.01%	2712
2025 Q3	$561	Buy	2 +1	+100%	+$272	﹤0.01%	2794
2025 Q2	$241	Sell	1 -5	-83%	-$1.18K	﹤0.01%	2903
2025 Q1	$1.46K	Sell	6 -24	-80%	-$7.22K	﹤0.01%	2103
2024 Q4	$9.86K	Buy	30 +1	+3%	+$339	﹤0.01%	1147
2024 Q3	$9.7K	Hold	29	–	–	﹤0.01%	1144
2024 Q2	$7.92K	Buy	29 +24	+480%	+$6.98K	﹤0.01%	1139
2024 Q1	$1.73K	Buy	5 +2	+67%	+$658	﹤0.01%	1225
2023 Q4	$969	Buy	+3	New	+$940	﹤0.01%	1196

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Rothschild Investment LLC's BIO Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Bio-Rad Laboratories Class A (BIO) stake by 11% in Q2 2026, selling an estimated $284 and leaving 8 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #2691.

Rothschild Investment LLC first reported a position in BIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.86K in Q4 2024. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Rothschild Investment LLC held 8 shares of Bio-Rad Laboratories Class A worth $2.35K as of Q2 2026.
Rothschild Investment LLC sold 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
Bio-Rad Laboratories Class A made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2691 holding.
Rothschild Investment LLC first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 11 quarters since.
Rothschild Investment LLC's Bio-Rad Laboratories Class A position peaked at $9.86K in Q4 2024.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.